3/17
08:58 am
livn
LivaNova PLC (NASDAQ: LIVN) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $64.00 price target on the stock.
Medium
Report
LivaNova PLC (NASDAQ: LIVN) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $64.00 price target on the stock.
3/7
08:18 am
livn
LivaNova PLC (NASDAQ: LIVN) had its price target lowered by analysts at Barclays PLC from $58.00 to $56.00. They now have an "equal weight" rating on the stock.
Low
Report
LivaNova PLC (NASDAQ: LIVN) had its price target lowered by analysts at Barclays PLC from $58.00 to $56.00. They now have an "equal weight" rating on the stock.
3/3
10:06 am
livn
LivaNova PLC (NASDAQ: LIVN) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $64.00 to $55.00. They now have a "buy" rating on the stock.
Low
Report
LivaNova PLC (NASDAQ: LIVN) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $64.00 to $55.00. They now have a "buy" rating on the stock.
2/27
12:08 am
livn
LivaNova PLC (NASDAQ: LIVN) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Low
Report
LivaNova PLC (NASDAQ: LIVN) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
2/26
11:36 am
livn
LivaNova PLC (NASDAQ: LIVN) had its price target lowered by analysts at Mizuho from $70.00 to $60.00. They now have an "outperform" rating on the stock.
Low
Report
LivaNova PLC (NASDAQ: LIVN) had its price target lowered by analysts at Mizuho from $70.00 to $60.00. They now have an "outperform" rating on the stock.
2/26
09:22 am
livn
LivaNova PLC (NASDAQ: LIVN) had its price target lowered by analysts at Stifel Nicolaus from $72.00 to $60.00. They now have a "buy" rating on the stock.
Low
Report
LivaNova PLC (NASDAQ: LIVN) had its price target lowered by analysts at Stifel Nicolaus from $72.00 to $60.00. They now have a "buy" rating on the stock.
2/26
08:00 am
livn
LivaNova PLC (NASDAQ: LIVN) had its price target lowered by analysts at Needham & Company LLC from $75.00 to $64.00. They now have a "buy" rating on the stock.
Low
Report
LivaNova PLC (NASDAQ: LIVN) had its price target lowered by analysts at Needham & Company LLC from $75.00 to $64.00. They now have a "buy" rating on the stock.
2/26
07:17 am
livn
LivaNova PLC (NASDAQ: LIVN) was downgraded by analysts at Wolfe Research from an "outperform" rating to a "peer perform" rating.
Low
Report
LivaNova PLC (NASDAQ: LIVN) was downgraded by analysts at Wolfe Research from an "outperform" rating to a "peer perform" rating.
2/26
06:44 am
livn
LivaNova Full Year 2024 Earnings: EPS Beats Expectations [Yahoo! Finance]
Low
Report
LivaNova Full Year 2024 Earnings: EPS Beats Expectations [Yahoo! Finance]
2/26
02:16 am
livn
LivaNova PLC (LIVN) Q4 2024 Earnings Call Highlights: Strong Organic Growth and Strategic ... [Yahoo! Finance]
Medium
Report
LivaNova PLC (LIVN) Q4 2024 Earnings Call Highlights: Strong Organic Growth and Strategic ... [Yahoo! Finance]
2/21
12:57 pm
livn
Getinge's surgical perfusion market exit ‘opens door' for LivaNova [Yahoo! Finance]
Low
Report
Getinge's surgical perfusion market exit ‘opens door' for LivaNova [Yahoo! Finance]
2/21
09:00 am
livn
LivaNova to Present at the Barclays Global Healthcare Conference
Low
Report
LivaNova to Present at the Barclays Global Healthcare Conference
2/14
10:01 pm
livn
LivaNova PLC (NASDAQ: LIVN) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Low
Report
LivaNova PLC (NASDAQ: LIVN) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
2/3
09:25 am
livn
Returns At LivaNova (NASDAQ:LIVN) Are On The Way Up [Yahoo! Finance]
Low
Report
Returns At LivaNova (NASDAQ:LIVN) Are On The Way Up [Yahoo! Finance]
1/30
07:46 pm
livn
Getinge exits surgical perfusion, creating opportunity for Livanova [Yahoo! Finance]
Low
Report
Getinge exits surgical perfusion, creating opportunity for Livanova [Yahoo! Finance]
1/28
08:33 am
livn
LivaNova PLC (NASDAQ: LIVN) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $75.00 price target on the stock.
Low
Report
LivaNova PLC (NASDAQ: LIVN) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $75.00 price target on the stock.
1/23
02:08 am
livn
LivaNova PLC (NASDAQ: LIVN) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Low
Report
LivaNova PLC (NASDAQ: LIVN) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
1/21
09:00 am
livn
LivaNova to Announce Fourth-Quarter and Full-Year 2024 Results
Low
Report
LivaNova to Announce Fourth-Quarter and Full-Year 2024 Results
1/15
11:01 pm
livn
LivaNova PLC (NASDAQ: LIVN) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Low
Report
LivaNova PLC (NASDAQ: LIVN) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
1/6
09:18 am
livn
LivaNova Appoints Natalia Kozmina as Chief Human Resources Officer [Yahoo! Finance]
Low
Report
LivaNova Appoints Natalia Kozmina as Chief Human Resources Officer [Yahoo! Finance]
1/6
09:00 am
livn
LivaNova Appoints Natalia Kozmina as Chief Human Resources Officer
Low
Report
LivaNova Appoints Natalia Kozmina as Chief Human Resources Officer
12/25
11:03 pm
livn
LivaNova PLC (NASDAQ: LIVN) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Low
Report
LivaNova PLC (NASDAQ: LIVN) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
12/19
02:41 pm
livn
How stimulating the body's largest nerve may relieve severe depression [CNN]
Low
Report
How stimulating the body's largest nerve may relieve severe depression [CNN]
12/19
01:11 pm
livn
For those with treatment-resistant depression, vagus nerve stimulation may be an answer, studies suggest [CNN]
Low
Report
For those with treatment-resistant depression, vagus nerve stimulation may be an answer, studies suggest [CNN]